Intraspinal Abscess Treatment Market size is anticipated to witness more than 10.2% CAGR during the forecast period i.e., between 2024-2036. Intraspinal abscesses are pus filled blisters between the spinal cord and backbone. This condition is rarer in comparison to intracranial abscesses, which are another type of epidural abscess, occurring in the skull. Intraspinal abscess can cause severe effects from chronic back pain, movement difficulties, to permanent disabilities. The pus is generated when any infection reaches the spine, generally through an unsafe surgery of back. The rising cases of sports injuries, affecting the lower back, along with injuries caused due to accidents and violence, are estimated to boost the market growth. The increasing investment in the R&D activities in the medical field, along with rising health awareness amongst the people is estimated to boost the market growth. Moreover, the developing public healthcare infrastructure and high government expenditure for the development of new drugs is anticipated to significantly fuel the growth of the intraspinal abscess treatment market.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
10.2% |
|
Regional Scope |
|
The market is segmented by treatment into antibiotic therapy, surgery, and others, out of which, the surgery segment is anticipated to hold the notable share in the intraspinal abscess treatment market over the forecast period on account of higher success rate of surgery. Moreover, surgery provides immediate treatment to severe cases of abscess and gives rapid relief. This is estimated to boost the segment growth.
Our in-depth analysis of the global market includes the following segments:
|
By Origin |
|
|
By Treatment |
|
|
By End-User |
|
On the basis of geographical analysis, the intraspinal abscess treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe is expected to account for largest revenue share by 2036, on the back of developing healthcare system, high disposable income of the individuals, and favorable health insurances available in developed countries, such as, the UK, Germany, France, Norway, and Others.
The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of increasing research activities for the development of new drugs, as it is a rare disease. Moreover, high healthcare expenditure is estimated to boost the market growth. According to the statistics by the World Bank, in 2018, the total healthcare expenditure of North America accounted for 16.415% of the total GDP.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?